Vision Infinitas makes Vision, an AI assistant for diabetes management built on CGM and insulin data.
Founded by Justin Lee and Sylvia Lee and based in San Francisco, US, Vision Infinitas sells subscription access to Vision, an AI tool for people with diabetes, caregivers and healthcare professionals. Vision uses continuous glucose monitoring and insulin data to give personalized answers around the clock on basal rates, insulin-to-carb ratios, sensitivity factors, nutrition, exercise and mental health support. Justin Lee is CEO. The company raised seed funding from SOSV and HAX in May 2019 and plans to enter Asia and Europe by 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in